A phase II study of docetaxel in combination with ZD1839 (gefitinib) in previously treated patients with metastatic pancreatic cancer
暂无分享,去创建一个
C. Earle | J. Meyerhardt | C. Fuchs | A. Zhu | P. Enzinger | D. Ryan | E. Kwak | M. Kulke | K. Stuart | L. Blaszkowsky